nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ABCG2—gout	0.451	1	CbGaD
Gefitinib—ALB—Naproxen—gout	0.0408	0.104	CbGbCtD
Gefitinib—ALB—Probenecid—gout	0.0277	0.0706	CbGbCtD
Gefitinib—ALB—Indomethacin—gout	0.0269	0.0688	CbGbCtD
Gefitinib—ABCG2—Hydrocortisone—gout	0.0241	0.0615	CbGbCtD
Gefitinib—CYP2C9—Naproxen—gout	0.022	0.0561	CbGbCtD
Gefitinib—CYP2C19—Probenecid—gout	0.0179	0.0458	CbGbCtD
Gefitinib—CYP2C19—Indomethacin—gout	0.0175	0.0446	CbGbCtD
Gefitinib—CYP2C9—Colchicine—gout	0.0166	0.0425	CbGbCtD
Gefitinib—ALB—Prednisone—gout	0.0165	0.0422	CbGbCtD
Gefitinib—ABCB1—Colchicine—gout	0.0162	0.0413	CbGbCtD
Gefitinib—CYP2C9—Probenecid—gout	0.0149	0.0381	CbGbCtD
Gefitinib—CYP2C9—Indomethacin—gout	0.0145	0.0371	CbGbCtD
Gefitinib—ABCB1—Probenecid—gout	0.0145	0.0369	CbGbCtD
Gefitinib—ABCB1—Methylprednisolone—gout	0.0143	0.0364	CbGbCtD
Gefitinib—ABCB1—Indomethacin—gout	0.0141	0.036	CbGbCtD
Gefitinib—CYP3A5—Hydrocortisone—gout	0.0133	0.0341	CbGbCtD
Gefitinib—CYP2C19—Prednisone—gout	0.0107	0.0274	CbGbCtD
Gefitinib—CYP3A4—Colchicine—gout	0.00968	0.0247	CbGbCtD
Gefitinib—ABCB1—Prednisolone—gout	0.00916	0.0234	CbGbCtD
Gefitinib—ABCB1—Hydrocortisone—gout	0.00868	0.0222	CbGbCtD
Gefitinib—CYP3A4—Probenecid—gout	0.00867	0.0221	CbGbCtD
Gefitinib—ABCB1—Prednisone—gout	0.00865	0.0221	CbGbCtD
Gefitinib—CYP3A4—Methylprednisolone—gout	0.00855	0.0218	CbGbCtD
Gefitinib—CYP3A4—Prednisolone—gout	0.00549	0.014	CbGbCtD
Gefitinib—CYP3A4—Hydrocortisone—gout	0.0052	0.0133	CbGbCtD
Gefitinib—CYP3A4—Prednisone—gout	0.00518	0.0132	CbGbCtD
Gefitinib—Afatinib—ABCG2—gout	0.00174	0.46	CrCbGaD
Gefitinib—IRAK1—IL1 and megakaryotyces in obesity—NLRP3—gout	0.00139	0.0786	CbGpPWpGaD
Gefitinib—Erlotinib—ABCG2—gout	0.00123	0.325	CrCbGaD
Gefitinib—ABCB1—Abacavir transmembrane transport—ABCG2—gout	0.000922	0.052	CbGpPWpGaD
Gefitinib—Vandetanib—ABCG2—gout	0.000812	0.214	CrCbGaD
Gefitinib—IRAK4—IL1-mediated signaling events—CASP1—gout	0.000776	0.0438	CbGpPWpGaD
Gefitinib—IRAK1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NLRP3—gout	0.000775	0.0437	CbGpPWpGaD
Gefitinib—IRAK4—IL1-mediated signaling events—IL1RN—gout	0.000751	0.0424	CbGpPWpGaD
Gefitinib—IRAK4—Interleukin-1 signaling—IL1RN—gout	0.00066	0.0372	CbGpPWpGaD
Gefitinib—IRAK1—NOD1/2 Signaling Pathway—CASP1—gout	0.000555	0.0313	CbGpPWpGaD
Gefitinib—CYP3A5—Irinotecan Pathway—ABCG2—gout	0.000536	0.0302	CbGpPWpGaD
Gefitinib—ABCB1—Abacavir transport and metabolism—ABCG2—gout	0.000529	0.0299	CbGpPWpGaD
Gefitinib—IRAK1—IL1-mediated signaling events—CASP1—gout	0.000515	0.029	CbGpPWpGaD
Gefitinib—IRAK1—IL1-mediated signaling events—IL1RN—gout	0.000499	0.0281	CbGpPWpGaD
Gefitinib—IRAK1—Interleukin-1 signaling—IL1RN—gout	0.000438	0.0247	CbGpPWpGaD
Gefitinib—IRAK1—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP1—gout	0.000378	0.0213	CbGpPWpGaD
Gefitinib—Eye disorder—Allopurinol—gout	0.000378	0.00285	CcSEcCtD
Gefitinib—Anaemia—Colchicine—gout	0.000377	0.00284	CcSEcCtD
Gefitinib—Cardiac disorder—Allopurinol—gout	0.000375	0.00283	CcSEcCtD
Gefitinib—Haematuria—Naproxen—gout	0.000375	0.00283	CcSEcCtD
Gefitinib—Angioedema—Colchicine—gout	0.000373	0.00281	CcSEcCtD
Gefitinib—Hepatobiliary disease—Naproxen—gout	0.000372	0.0028	CcSEcCtD
Gefitinib—Epistaxis—Naproxen—gout	0.000371	0.0028	CcSEcCtD
Gefitinib—Anaemia—Indomethacin—gout	0.000358	0.0027	CcSEcCtD
Gefitinib—Alopecia—Allopurinol—gout	0.000357	0.00269	CcSEcCtD
Gefitinib—Haemoglobin—Naproxen—gout	0.000355	0.00267	CcSEcCtD
Gefitinib—Angioedema—Indomethacin—gout	0.000354	0.00267	CcSEcCtD
Gefitinib—Haemorrhage—Naproxen—gout	0.000353	0.00266	CcSEcCtD
Gefitinib—Hepatitis—Naproxen—gout	0.000353	0.00266	CcSEcCtD
Gefitinib—Malnutrition—Allopurinol—gout	0.000352	0.00265	CcSEcCtD
Gefitinib—Malaise—Indomethacin—gout	0.00035	0.00264	CcSEcCtD
Gefitinib—Urinary tract disorder—Naproxen—gout	0.000348	0.00263	CcSEcCtD
Gefitinib—Oedema peripheral—Naproxen—gout	0.000348	0.00262	CcSEcCtD
Gefitinib—Urethral disorder—Naproxen—gout	0.000346	0.00261	CcSEcCtD
Gefitinib—Dry eye—Hydrocortisone—gout	0.000337	0.00254	CcSEcCtD
Gefitinib—Erythema multiforme—Naproxen—gout	0.000334	0.00252	CcSEcCtD
Gefitinib—Eye disorder—Naproxen—gout	0.00033	0.00249	CcSEcCtD
Gefitinib—CSNK1E—Danazol—Hydrocortisone—gout	0.000328	0.112	CbGdCrCtD
Gefitinib—Shock—Colchicine—gout	0.000328	0.00247	CcSEcCtD
Gefitinib—Cardiac disorder—Naproxen—gout	0.000328	0.00247	CcSEcCtD
Gefitinib—Nervous system disorder—Colchicine—gout	0.000327	0.00246	CcSEcCtD
Gefitinib—Thrombocytopenia—Colchicine—gout	0.000326	0.00246	CcSEcCtD
Gefitinib—Anaemia—Allopurinol—gout	0.000325	0.00245	CcSEcCtD
Gefitinib—Skin disorder—Colchicine—gout	0.000324	0.00244	CcSEcCtD
Gefitinib—Acne—Prednisone—gout	0.000322	0.00243	CcSEcCtD
Gefitinib—Angioedema—Allopurinol—gout	0.000321	0.00242	CcSEcCtD
Gefitinib—Angiopathy—Naproxen—gout	0.00032	0.00241	CcSEcCtD
Gefitinib—Mediastinal disorder—Naproxen—gout	0.000318	0.0024	CcSEcCtD
Gefitinib—Malaise—Allopurinol—gout	0.000317	0.00239	CcSEcCtD
Gefitinib—Arrhythmia—Naproxen—gout	0.000315	0.00238	CcSEcCtD
Gefitinib—Thrombophlebitis—Prednisolone—gout	0.000313	0.00236	CcSEcCtD
Gefitinib—Alopecia—Naproxen—gout	0.000312	0.00235	CcSEcCtD
Gefitinib—Shock—Indomethacin—gout	0.000311	0.00235	CcSEcCtD
Gefitinib—Hypotension—Colchicine—gout	0.000311	0.00235	CcSEcCtD
Gefitinib—Thrombocytopenia—Indomethacin—gout	0.00031	0.00234	CcSEcCtD
Gefitinib—IRAK4—Signaling by Interleukins—CASP1—gout	0.000308	0.0174	CbGpPWpGaD
Gefitinib—Malnutrition—Naproxen—gout	0.000307	0.00232	CcSEcCtD
Gefitinib—Thrombophlebitis—Hydrocortisone—gout	0.000306	0.0023	CcSEcCtD
Gefitinib—Anorexia—Indomethacin—gout	0.000302	0.00227	CcSEcCtD
Gefitinib—IRAK4—Signaling by Interleukins—IL1RN—gout	0.000298	0.0168	CbGpPWpGaD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Allopurinol—gout	0.000297	0.00224	CcSEcCtD
Gefitinib—Hypotension—Indomethacin—gout	0.000296	0.00223	CcSEcCtD
Gefitinib—MKNK1—MAPK Signaling Pathway—CASP1—gout	0.000291	0.0164	CbGpPWpGaD
Gefitinib—Decreased appetite—Colchicine—gout	0.00029	0.00218	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Colchicine—gout	0.000288	0.00217	CcSEcCtD
Gefitinib—Fatigue—Colchicine—gout	0.000287	0.00216	CcSEcCtD
Gefitinib—Thrombophlebitis—Methylprednisolone—gout	0.000287	0.00216	CcSEcCtD
Gefitinib—Ulcer—Prednisone—gout	0.000287	0.00216	CcSEcCtD
Gefitinib—Infection—Allopurinol—gout	0.000285	0.00215	CcSEcCtD
Gefitinib—Anaemia—Naproxen—gout	0.000284	0.00214	CcSEcCtD
Gefitinib—Dermatitis bullous—Prednisolone—gout	0.000283	0.00214	CcSEcCtD
Gefitinib—CSNK1E—Danazol—Prednisone—gout	0.000283	0.0967	CbGdCrCtD
Gefitinib—Dyspnoea—Indomethacin—gout	0.000282	0.00213	CcSEcCtD
Gefitinib—Nervous system disorder—Allopurinol—gout	0.000282	0.00212	CcSEcCtD
Gefitinib—Thrombocytopenia—Allopurinol—gout	0.000281	0.00212	CcSEcCtD
Gefitinib—Angioedema—Naproxen—gout	0.000281	0.00212	CcSEcCtD
Gefitinib—Skin disorder—Allopurinol—gout	0.000279	0.0021	CcSEcCtD
Gefitinib—Malaise—Naproxen—gout	0.000277	0.00209	CcSEcCtD
Gefitinib—Decreased appetite—Indomethacin—gout	0.000275	0.00207	CcSEcCtD
Gefitinib—Anorexia—Allopurinol—gout	0.000274	0.00206	CcSEcCtD
Gefitinib—Fatigue—Indomethacin—gout	0.000273	0.00206	CcSEcCtD
Gefitinib—Gastrointestinal pain—Colchicine—gout	0.000272	0.00205	CcSEcCtD
Gefitinib—Pain—Indomethacin—gout	0.000271	0.00204	CcSEcCtD
Gefitinib—Constipation—Indomethacin—gout	0.000271	0.00204	CcSEcCtD
Gefitinib—Hypotension—Allopurinol—gout	0.000268	0.00202	CcSEcCtD
Gefitinib—Cough—Naproxen—gout	0.000268	0.00202	CcSEcCtD
Gefitinib—Urticaria—Colchicine—gout	0.000265	0.00199	CcSEcCtD
Gefitinib—Abdominal pain—Colchicine—gout	0.000263	0.00198	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Naproxen—gout	0.00026	0.00196	CcSEcCtD
Gefitinib—Gastrointestinal pain—Indomethacin—gout	0.000259	0.00195	CcSEcCtD
Gefitinib—Dry mouth—Naproxen—gout	0.000256	0.00193	CcSEcCtD
Gefitinib—Urticaria—Indomethacin—gout	0.000251	0.0019	CcSEcCtD
Gefitinib—Body temperature increased—Indomethacin—gout	0.00025	0.00189	CcSEcCtD
Gefitinib—Abdominal pain—Indomethacin—gout	0.00025	0.00189	CcSEcCtD
Gefitinib—Decreased appetite—Allopurinol—gout	0.00025	0.00188	CcSEcCtD
Gefitinib—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.000249	0.0141	CbGpPWpGaD
Gefitinib—Infection—Naproxen—gout	0.000249	0.00188	CcSEcCtD
Gefitinib—Dry skin—Prednisolone—gout	0.000248	0.00187	CcSEcCtD
Gefitinib—EGFR—Syndecan-3-mediated signaling events—POMC—gout	0.000248	0.014	CbGpPWpGaD
Gefitinib—Gastrointestinal disorder—Allopurinol—gout	0.000248	0.00187	CcSEcCtD
Gefitinib—Shock—Naproxen—gout	0.000247	0.00186	CcSEcCtD
Gefitinib—Nervous system disorder—Naproxen—gout	0.000246	0.00185	CcSEcCtD
Gefitinib—Pain—Allopurinol—gout	0.000246	0.00185	CcSEcCtD
Gefitinib—Constipation—Allopurinol—gout	0.000246	0.00185	CcSEcCtD
Gefitinib—Thrombocytopenia—Naproxen—gout	0.000245	0.00185	CcSEcCtD
Gefitinib—Hypersensitivity—Colchicine—gout	0.000245	0.00185	CcSEcCtD
Gefitinib—Skin disorder—Naproxen—gout	0.000244	0.00184	CcSEcCtD
Gefitinib—Dry skin—Hydrocortisone—gout	0.000242	0.00183	CcSEcCtD
Gefitinib—Hypokalaemia—Hydrocortisone—gout	0.000241	0.00182	CcSEcCtD
Gefitinib—Anorexia—Naproxen—gout	0.000239	0.0018	CcSEcCtD
Gefitinib—Asthenia—Colchicine—gout	0.000239	0.0018	CcSEcCtD
Gefitinib—Gastrointestinal pain—Allopurinol—gout	0.000235	0.00177	CcSEcCtD
Gefitinib—IRAK1—Apoptosis Modulation and Signaling—CASP1—gout	0.000234	0.0132	CbGpPWpGaD
Gefitinib—Hypotension—Naproxen—gout	0.000234	0.00177	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Hydrocortisone—gout	0.000233	0.00176	CcSEcCtD
Gefitinib—Hypersensitivity—Indomethacin—gout	0.000233	0.00176	CcSEcCtD
Gefitinib—Pancreatitis—Prednisolone—gout	0.00023	0.00173	CcSEcCtD
Gefitinib—Urticaria—Allopurinol—gout	0.000228	0.00172	CcSEcCtD
Gefitinib—Diarrhoea—Colchicine—gout	0.000228	0.00172	CcSEcCtD
Gefitinib—Thrombophlebitis—Prednisone—gout	0.000227	0.00171	CcSEcCtD
Gefitinib—Asthenia—Indomethacin—gout	0.000227	0.00171	CcSEcCtD
Gefitinib—Abdominal pain—Allopurinol—gout	0.000227	0.00171	CcSEcCtD
Gefitinib—Body temperature increased—Allopurinol—gout	0.000227	0.00171	CcSEcCtD
Gefitinib—Pancreatitis—Hydrocortisone—gout	0.000224	0.00169	CcSEcCtD
Gefitinib—Pruritus—Indomethacin—gout	0.000224	0.00169	CcSEcCtD
Gefitinib—Dyspnoea—Naproxen—gout	0.000224	0.00169	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Methylprednisolone—gout	0.000219	0.00165	CcSEcCtD
Gefitinib—Decreased appetite—Naproxen—gout	0.000218	0.00164	CcSEcCtD
Gefitinib—Diarrhoea—Indomethacin—gout	0.000217	0.00163	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Naproxen—gout	0.000216	0.00163	CcSEcCtD
Gefitinib—Fatigue—Naproxen—gout	0.000216	0.00163	CcSEcCtD
Gefitinib—Constipation—Naproxen—gout	0.000214	0.00162	CcSEcCtD
Gefitinib—Pain—Naproxen—gout	0.000214	0.00162	CcSEcCtD
Gefitinib—Vomiting—Colchicine—gout	0.000212	0.0016	CcSEcCtD
Gefitinib—Hypersensitivity—Allopurinol—gout	0.000212	0.00159	CcSEcCtD
Gefitinib—Pancreatitis—Methylprednisolone—gout	0.000211	0.00159	CcSEcCtD
Gefitinib—Rash—Colchicine—gout	0.00021	0.00158	CcSEcCtD
Gefitinib—Dermatitis—Colchicine—gout	0.00021	0.00158	CcSEcCtD
Gefitinib—CSNK1E—Dexamethasone—Hydrocortisone—gout	0.00021	0.0717	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Hydrocortisone—gout	0.00021	0.0717	CbGdCrCtD
Gefitinib—Weight decreased—Hydrocortisone—gout	0.000207	0.00156	CcSEcCtD
Gefitinib—Asthenia—Allopurinol—gout	0.000206	0.00155	CcSEcCtD
Gefitinib—Gastrointestinal pain—Naproxen—gout	0.000205	0.00155	CcSEcCtD
Gefitinib—IRAK1—Signaling by Interleukins—CASP1—gout	0.000204	0.0115	CbGpPWpGaD
Gefitinib—Infestation—Hydrocortisone—gout	0.000204	0.00154	CcSEcCtD
Gefitinib—Infestation NOS—Hydrocortisone—gout	0.000204	0.00154	CcSEcCtD
Gefitinib—Pruritus—Allopurinol—gout	0.000203	0.00153	CcSEcCtD
Gefitinib—Conjunctivitis—Prednisolone—gout	0.000203	0.00153	CcSEcCtD
Gefitinib—CHEK2—Testosterone Propionate—Hydrocortisone—gout	0.000202	0.0691	CbGdCrCtD
Gefitinib—Vomiting—Indomethacin—gout	0.000201	0.00152	CcSEcCtD
Gefitinib—Rash—Indomethacin—gout	0.0002	0.0015	CcSEcCtD
Gefitinib—Dermatitis—Indomethacin—gout	0.000199	0.0015	CcSEcCtD
Gefitinib—Urticaria—Naproxen—gout	0.000199	0.0015	CcSEcCtD
Gefitinib—Body temperature increased—Naproxen—gout	0.000198	0.00149	CcSEcCtD
Gefitinib—Abdominal pain—Naproxen—gout	0.000198	0.00149	CcSEcCtD
Gefitinib—IRAK1—Signaling by Interleukins—IL1RN—gout	0.000198	0.0112	CbGpPWpGaD
Gefitinib—Nausea—Colchicine—gout	0.000198	0.00149	CcSEcCtD
Gefitinib—CSNK1E—Dexamethasone—Methylprednisolone—gout	0.000198	0.0676	CbGdCrCtD
Gefitinib—CSNK1E—Betamethasone—Methylprednisolone—gout	0.000198	0.0676	CbGdCrCtD
Gefitinib—Diarrhoea—Allopurinol—gout	0.000196	0.00148	CcSEcCtD
Gefitinib—Infestation NOS—Methylprednisolone—gout	0.000192	0.00144	CcSEcCtD
Gefitinib—Infestation—Methylprednisolone—gout	0.000192	0.00144	CcSEcCtD
Gefitinib—Haemoglobin—Prednisolone—gout	0.000188	0.00142	CcSEcCtD
Gefitinib—Nausea—Indomethacin—gout	0.000188	0.00142	CcSEcCtD
Gefitinib—Haemorrhage—Prednisolone—gout	0.000187	0.00141	CcSEcCtD
Gefitinib—Hypersensitivity—Naproxen—gout	0.000185	0.00139	CcSEcCtD
Gefitinib—Haemoglobin—Hydrocortisone—gout	0.000184	0.00139	CcSEcCtD
Gefitinib—Haemorrhage—Hydrocortisone—gout	0.000183	0.00138	CcSEcCtD
Gefitinib—Vomiting—Allopurinol—gout	0.000183	0.00138	CcSEcCtD
Gefitinib—Rash—Allopurinol—gout	0.000181	0.00136	CcSEcCtD
Gefitinib—Dermatitis—Allopurinol—gout	0.000181	0.00136	CcSEcCtD
Gefitinib—Dry skin—Prednisone—gout	0.00018	0.00136	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Prednisone—gout	0.00018	0.0617	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisone—gout	0.00018	0.0617	CbGdCrCtD
Gefitinib—MKNK1—Disease—PRPS1—gout	0.00018	0.0102	CbGpPWpGaD
Gefitinib—MKNK1—Disease—PRPS2—gout	0.00018	0.0102	CbGpPWpGaD
Gefitinib—Asthenia—Naproxen—gout	0.00018	0.00136	CcSEcCtD
Gefitinib—Hypokalaemia—Prednisone—gout	0.000179	0.00135	CcSEcCtD
Gefitinib—MAP2K5—MAPK Signaling Pathway—CASP1—gout	0.000179	0.0101	CbGpPWpGaD
Gefitinib—Pruritus—Naproxen—gout	0.000177	0.00134	CcSEcCtD
Gefitinib—CSNK1E—Betamethasone—Prednisolone—gout	0.000176	0.0602	CbGdCrCtD
Gefitinib—CSNK1E—Dexamethasone—Prednisolone—gout	0.000176	0.0602	CbGdCrCtD
Gefitinib—Alanine aminotransferase increased—Prednisone—gout	0.000174	0.00131	CcSEcCtD
Gefitinib—Haemoglobin—Methylprednisolone—gout	0.000173	0.0013	CcSEcCtD
Gefitinib—Haemorrhage—Methylprednisolone—gout	0.000172	0.0013	CcSEcCtD
Gefitinib—Diarrhoea—Naproxen—gout	0.000172	0.00129	CcSEcCtD
Gefitinib—Eye disorder—Hydrocortisone—gout	0.000171	0.00129	CcSEcCtD
Gefitinib—Nausea—Allopurinol—gout	0.000171	0.00129	CcSEcCtD
Gefitinib—CHEK2—Danazol—Hydrocortisone—gout	0.000168	0.0575	CbGdCrCtD
Gefitinib—Arrhythmia—Prednisolone—gout	0.000167	0.00126	CcSEcCtD
Gefitinib—Pancreatitis—Prednisone—gout	0.000167	0.00126	CcSEcCtD
Gefitinib—IRAK4—Innate Immune System—NLRP3—gout	0.000165	0.0093	CbGpPWpGaD
Gefitinib—Arrhythmia—Hydrocortisone—gout	0.000163	0.00123	CcSEcCtD
Gefitinib—Eye disorder—Methylprednisolone—gout	0.000161	0.00121	CcSEcCtD
Gefitinib—Cardiac disorder—Methylprednisolone—gout	0.00016	0.0012	CcSEcCtD
Gefitinib—Vomiting—Naproxen—gout	0.000159	0.0012	CcSEcCtD
Gefitinib—Malnutrition—Hydrocortisone—gout	0.000159	0.0012	CcSEcCtD
Gefitinib—Rash—Naproxen—gout	0.000158	0.00119	CcSEcCtD
Gefitinib—Dermatitis—Naproxen—gout	0.000158	0.00119	CcSEcCtD
Gefitinib—Angiopathy—Methylprednisolone—gout	0.000156	0.00118	CcSEcCtD
Gefitinib—Mediastinal disorder—Methylprednisolone—gout	0.000155	0.00117	CcSEcCtD
Gefitinib—Weight decreased—Prednisone—gout	0.000154	0.00116	CcSEcCtD
Gefitinib—Arrhythmia—Methylprednisolone—gout	0.000154	0.00116	CcSEcCtD
Gefitinib—CHEK2—Norethindrone—Hydrocortisone—gout	0.000151	0.0518	CbGdCrCtD
Gefitinib—Malnutrition—Methylprednisolone—gout	0.00015	0.00113	CcSEcCtD
Gefitinib—Angioedema—Prednisolone—gout	0.000149	0.00112	CcSEcCtD
Gefitinib—Nausea—Naproxen—gout	0.000149	0.00112	CcSEcCtD
Gefitinib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000148	0.00837	CbGpPWpGaD
Gefitinib—Malaise—Prednisolone—gout	0.000147	0.00111	CcSEcCtD
Gefitinib—Angioedema—Hydrocortisone—gout	0.000146	0.0011	CcSEcCtD
Gefitinib—CHEK2—Danazol—Prednisone—gout	0.000145	0.0495	CbGdCrCtD
Gefitinib—Malaise—Hydrocortisone—gout	0.000144	0.00108	CcSEcCtD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—CASP1—gout	0.000144	0.0081	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—PRPS1—gout	0.00014	0.0079	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—PRPS2—gout	0.00014	0.0079	CbGpPWpGaD
Gefitinib—IRAK4—Cytokine Signaling in Immune system—IL1RN—gout	0.000139	0.00785	CbGpPWpGaD
Gefitinib—Haemoglobin—Prednisone—gout	0.000137	0.00103	CcSEcCtD
Gefitinib—Angioedema—Methylprednisolone—gout	0.000137	0.00103	CcSEcCtD
Gefitinib—Haemorrhage—Prednisone—gout	0.000136	0.00103	CcSEcCtD
Gefitinib—Malaise—Methylprednisolone—gout	0.000135	0.00102	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	0.000135	0.00102	CcSEcCtD
Gefitinib—ERBB3—Innate Immune System—NLRP3—gout	0.000132	0.00742	CbGpPWpGaD
Gefitinib—Shock—Prednisolone—gout	0.000131	0.000987	CcSEcCtD
Gefitinib—Infection—Hydrocortisone—gout	0.000129	0.000974	CcSEcCtD
Gefitinib—Shock—Hydrocortisone—gout	0.000128	0.000964	CcSEcCtD
Gefitinib—Nervous system disorder—Hydrocortisone—gout	0.000128	0.000961	CcSEcCtD
Gefitinib—Eye disorder—Prednisone—gout	0.000127	0.000959	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	0.000127	0.000954	CcSEcCtD
Gefitinib—Skin disorder—Hydrocortisone—gout	0.000126	0.000952	CcSEcCtD
Gefitinib—Anorexia—Hydrocortisone—gout	0.000124	0.000934	CcSEcCtD
Gefitinib—Angiopathy—Prednisone—gout	0.000124	0.000931	CcSEcCtD
Gefitinib—ABCG2—Transmembrane transport of small molecules—SLC17A3—gout	0.000122	0.00686	CbGpPWpGaD
Gefitinib—Arrhythmia—Prednisone—gout	0.000122	0.000917	CcSEcCtD
Gefitinib—Hypotension—Hydrocortisone—gout	0.000122	0.000916	CcSEcCtD
Gefitinib—Infection—Methylprednisolone—gout	0.000121	0.000915	CcSEcCtD
Gefitinib—ALB—SLC-mediated transmembrane transport—SLC22A11—gout	0.00012	0.00679	CbGpPWpGaD
Gefitinib—ALB—SLC-mediated transmembrane transport—SLC17A1—gout	0.00012	0.00679	CbGpPWpGaD
Gefitinib—CHEK2—Levonorgestrel—Hydrocortisone—gout	0.00012	0.0412	CbGdCrCtD
Gefitinib—Alopecia—Prednisone—gout	0.00012	0.000907	CcSEcCtD
Gefitinib—Shock—Methylprednisolone—gout	0.00012	0.000906	CcSEcCtD
Gefitinib—Nervous system disorder—Methylprednisolone—gout	0.00012	0.000903	CcSEcCtD
Gefitinib—Skin disorder—Methylprednisolone—gout	0.000119	0.000895	CcSEcCtD
Gefitinib—Malnutrition—Prednisone—gout	0.000119	0.000894	CcSEcCtD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—ABCG2—gout	0.000117	0.0066	CbGpPWpGaD
Gefitinib—Hypotension—Methylprednisolone—gout	0.000114	0.000861	CcSEcCtD
Gefitinib—Pain—Prednisolone—gout	0.000114	0.000858	CcSEcCtD
Gefitinib—Decreased appetite—Hydrocortisone—gout	0.000113	0.000852	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Hydrocortisone—gout	0.000112	0.000846	CcSEcCtD
Gefitinib—Fatigue—Hydrocortisone—gout	0.000112	0.000845	CcSEcCtD
Gefitinib—Pain—Hydrocortisone—gout	0.000111	0.000838	CcSEcCtD
Gefitinib—EGFR—Direct p53 effectors—CASP1—gout	0.000111	0.00626	CbGpPWpGaD
Gefitinib—Anaemia—Prednisone—gout	0.00011	0.000826	CcSEcCtD
Gefitinib—IRAK1—Innate Immune System—NLRP3—gout	0.000109	0.00617	CbGpPWpGaD
Gefitinib—Angioedema—Prednisone—gout	0.000108	0.000817	CcSEcCtD
Gefitinib—Malaise—Prednisone—gout	0.000107	0.000806	CcSEcCtD
Gefitinib—ERBB3—Disease—PRPS1—gout	0.000107	0.00602	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PRPS2—gout	0.000107	0.00602	CbGpPWpGaD
Gefitinib—Gastrointestinal pain—Hydrocortisone—gout	0.000106	0.000802	CcSEcCtD
Gefitinib—Urticaria—Prednisolone—gout	0.000106	0.000797	CcSEcCtD
Gefitinib—Fatigue—Methylprednisolone—gout	0.000105	0.000794	CcSEcCtD
Gefitinib—Urticaria—Hydrocortisone—gout	0.000103	0.000779	CcSEcCtD
Gefitinib—Body temperature increased—Hydrocortisone—gout	0.000103	0.000775	CcSEcCtD
Gefitinib—Abdominal pain—Hydrocortisone—gout	0.000103	0.000775	CcSEcCtD
Gefitinib—ALB—Hemostasis—LRRC16A—gout	0.000102	0.00575	CbGpPWpGaD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	0.0001	0.000756	CcSEcCtD
Gefitinib—Gastrointestinal pain—Methylprednisolone—gout	9.99e-05	0.000753	CcSEcCtD
Gefitinib—ABCG2—Transmembrane transport of small molecules—SLC22A11—gout	9.92e-05	0.0056	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—SLC17A1—gout	9.92e-05	0.0056	CbGpPWpGaD
Gefitinib—Hypersensitivity—Prednisolone—gout	9.81e-05	0.000739	CcSEcCtD
Gefitinib—Urticaria—Methylprednisolone—gout	9.7e-05	0.000732	CcSEcCtD
Gefitinib—Abdominal pain—Methylprednisolone—gout	9.66e-05	0.000728	CcSEcCtD
Gefitinib—Infection—Prednisone—gout	9.61e-05	0.000725	CcSEcCtD
Gefitinib—IRAK4—Immune System—NLRP3—gout	9.61e-05	0.00542	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—CASP1—gout	9.59e-05	0.00541	CbGpPWpGaD
Gefitinib—Hypersensitivity—Hydrocortisone—gout	9.58e-05	0.000722	CcSEcCtD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—CASP1—gout	9.53e-05	0.00538	CbGpPWpGaD
Gefitinib—Shock—Prednisone—gout	9.52e-05	0.000718	CcSEcCtD
Gefitinib—Nervous system disorder—Prednisone—gout	9.49e-05	0.000715	CcSEcCtD
Gefitinib—Skin disorder—Prednisone—gout	9.4e-05	0.000708	CcSEcCtD
Gefitinib—Asthenia—Hydrocortisone—gout	9.33e-05	0.000703	CcSEcCtD
Gefitinib—IRAK1—Cytokine Signaling in Immune system—IL1RN—gout	9.23e-05	0.00521	CbGpPWpGaD
Gefitinib—Anorexia—Prednisone—gout	9.22e-05	0.000695	CcSEcCtD
Gefitinib—Pruritus—Hydrocortisone—gout	9.2e-05	0.000694	CcSEcCtD
Gefitinib—ALB—SLC-mediated transmembrane transport—SLC22A12—gout	9.13e-05	0.00515	CbGpPWpGaD
Gefitinib—Hypersensitivity—Methylprednisolone—gout	9e-05	0.000679	CcSEcCtD
Gefitinib—Diarrhoea—Hydrocortisone—gout	8.9e-05	0.000671	CcSEcCtD
Gefitinib—Asthenia—Methylprednisolone—gout	8.76e-05	0.000661	CcSEcCtD
Gefitinib—Pruritus—Methylprednisolone—gout	8.64e-05	0.000652	CcSEcCtD
Gefitinib—ALB—SLC-mediated transmembrane transport—SLC2A9—gout	8.49e-05	0.00479	CbGpPWpGaD
Gefitinib—Decreased appetite—Prednisone—gout	8.41e-05	0.000634	CcSEcCtD
Gefitinib—Rash—Prednisolone—gout	8.39e-05	0.000633	CcSEcCtD
Gefitinib—Dermatitis—Prednisolone—gout	8.39e-05	0.000632	CcSEcCtD
Gefitinib—Diarrhoea—Methylprednisolone—gout	8.36e-05	0.00063	CcSEcCtD
Gefitinib—Fatigue—Prednisone—gout	8.34e-05	0.000629	CcSEcCtD
Gefitinib—Constipation—Prednisone—gout	8.27e-05	0.000624	CcSEcCtD
Gefitinib—Vomiting—Hydrocortisone—gout	8.27e-05	0.000623	CcSEcCtD
Gefitinib—Rash—Hydrocortisone—gout	8.2e-05	0.000618	CcSEcCtD
Gefitinib—Dermatitis—Hydrocortisone—gout	8.19e-05	0.000618	CcSEcCtD
Gefitinib—IRAK4—Innate Immune System—CASP1—gout	8.06e-05	0.00454	CbGpPWpGaD
Gefitinib—Gastrointestinal pain—Prednisone—gout	7.91e-05	0.000596	CcSEcCtD
Gefitinib—Nausea—Prednisolone—gout	7.91e-05	0.000596	CcSEcCtD
Gefitinib—Vomiting—Methylprednisolone—gout	7.77e-05	0.000586	CcSEcCtD
Gefitinib—Nausea—Hydrocortisone—gout	7.72e-05	0.000582	CcSEcCtD
Gefitinib—Rash—Methylprednisolone—gout	7.7e-05	0.000581	CcSEcCtD
Gefitinib—Dermatitis—Methylprednisolone—gout	7.7e-05	0.00058	CcSEcCtD
Gefitinib—Urticaria—Prednisone—gout	7.69e-05	0.000579	CcSEcCtD
Gefitinib—ERBB3—Immune System—NLRP3—gout	7.66e-05	0.00432	CbGpPWpGaD
Gefitinib—Abdominal pain—Prednisone—gout	7.65e-05	0.000577	CcSEcCtD
Gefitinib—Body temperature increased—Prednisone—gout	7.65e-05	0.000577	CcSEcCtD
Gefitinib—ABCG2—Transmembrane transport of small molecules—SLC22A12—gout	7.52e-05	0.00424	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC17A3—gout	7.51e-05	0.00424	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NLRP3—gout	7.32e-05	0.00413	CbGpPWpGaD
Gefitinib—Nausea—Methylprednisolone—gout	7.26e-05	0.000547	CcSEcCtD
Gefitinib—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—gout	7.16e-05	0.00404	CbGpPWpGaD
Gefitinib—Hypersensitivity—Prednisone—gout	7.13e-05	0.000537	CcSEcCtD
Gefitinib—ABCG2—Transmembrane transport of small molecules—SLC2A9—gout	6.99e-05	0.00394	CbGpPWpGaD
Gefitinib—Asthenia—Prednisone—gout	6.94e-05	0.000523	CcSEcCtD
Gefitinib—Pruritus—Prednisone—gout	6.84e-05	0.000516	CcSEcCtD
Gefitinib—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—gout	6.77e-05	0.00382	CbGpPWpGaD
Gefitinib—Diarrhoea—Prednisone—gout	6.62e-05	0.000499	CcSEcCtD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC17A3—gout	6.58e-05	0.00371	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—CASP1—gout	6.42e-05	0.00362	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NLRP3—gout	6.38e-05	0.0036	CbGpPWpGaD
Gefitinib—Vomiting—Prednisone—gout	6.15e-05	0.000464	CcSEcCtD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC17A1—gout	6.12e-05	0.00345	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC22A11—gout	6.12e-05	0.00345	CbGpPWpGaD
Gefitinib—Rash—Prednisone—gout	6.1e-05	0.00046	CcSEcCtD
Gefitinib—Dermatitis—Prednisone—gout	6.09e-05	0.000459	CcSEcCtD
Gefitinib—EGFR—Disease—PRPS1—gout	5.94e-05	0.00335	CbGpPWpGaD
Gefitinib—EGFR—Disease—PRPS2—gout	5.94e-05	0.00335	CbGpPWpGaD
Gefitinib—CYP3A5—Phase 1 - Functionalization of compounds—POMC—gout	5.81e-05	0.00328	CbGpPWpGaD
Gefitinib—Nausea—Prednisone—gout	5.75e-05	0.000433	CcSEcCtD
Gefitinib—ABCG2—Metabolism—BCKDHA—gout	5.7e-05	0.00321	CbGpPWpGaD
Gefitinib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—gout	5.54e-05	0.00312	CbGpPWpGaD
Gefitinib—CYP1A1—Phase 1 - Functionalization of compounds—POMC—gout	5.49e-05	0.00309	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC17A1—gout	5.36e-05	0.00303	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC22A11—gout	5.36e-05	0.00303	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—CASP1—gout	5.35e-05	0.00302	CbGpPWpGaD
Gefitinib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—gout	5.09e-05	0.00287	CbGpPWpGaD
Gefitinib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—gout	5.05e-05	0.00285	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CASP1—gout	4.69e-05	0.00265	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—HPRT1—gout	4.65e-05	0.00262	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PRPS2—gout	4.65e-05	0.00262	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PRPS1—gout	4.65e-05	0.00262	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC22A12—gout	4.64e-05	0.00262	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—IL1RN—gout	4.54e-05	0.00256	CbGpPWpGaD
Gefitinib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—gout	4.49e-05	0.00253	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—SLC2A9—gout	4.31e-05	0.00243	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NLRP3—gout	4.26e-05	0.0024	CbGpPWpGaD
Gefitinib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—gout	4.13e-05	0.00233	CbGpPWpGaD
Gefitinib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—gout	4.09e-05	0.00231	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—BCKDHA—gout	4.08e-05	0.0023	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC22A12—gout	4.06e-05	0.00229	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—BCKDHA—gout	3.86e-05	0.00218	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—SLC2A9—gout	3.78e-05	0.00213	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CASP1—gout	3.74e-05	0.00211	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—IL1RN—gout	3.62e-05	0.00204	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CASP1—gout	3.58e-05	0.00202	CbGpPWpGaD
Gefitinib—ALB—Metabolism—BCKDHA—gout	3.52e-05	0.00198	CbGpPWpGaD
Gefitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	3.33e-05	0.00188	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PRPS2—gout	3.33e-05	0.00188	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—HPRT1—gout	3.33e-05	0.00188	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PRPS1—gout	3.33e-05	0.00188	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—BCKDHA—gout	3.16e-05	0.00178	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PRPS1—gout	3.15e-05	0.00177	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—HPRT1—gout	3.15e-05	0.00177	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PRPS2—gout	3.15e-05	0.00177	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CASP1—gout	3.11e-05	0.00176	CbGpPWpGaD
Gefitinib—CYP3A5—Biological oxidations—POMC—gout	3.09e-05	0.00174	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—BCKDHA—gout	3.08e-05	0.00174	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—IL1RN—gout	3.02e-05	0.0017	CbGpPWpGaD
Gefitinib—CYP1A1—Biological oxidations—POMC—gout	2.91e-05	0.00164	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—BCKDHA—gout	2.9e-05	0.00164	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—BCKDHA—gout	2.88e-05	0.00162	CbGpPWpGaD
Gefitinib—ALB—Metabolism—HPRT1—gout	2.87e-05	0.00162	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PRPS1—gout	2.87e-05	0.00162	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PRPS2—gout	2.87e-05	0.00162	CbGpPWpGaD
Gefitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	2.7e-05	0.00152	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PRPS1—gout	2.57e-05	0.00145	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—HPRT1—gout	2.57e-05	0.00145	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PRPS2—gout	2.57e-05	0.00145	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PRPS1—gout	2.51e-05	0.00142	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—HPRT1—gout	2.51e-05	0.00142	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PRPS2—gout	2.51e-05	0.00142	CbGpPWpGaD
Gefitinib—CYP2C19—Biological oxidations—POMC—gout	2.39e-05	0.00135	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PRPS2—gout	2.37e-05	0.00134	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PRPS1—gout	2.37e-05	0.00134	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—HPRT1—gout	2.37e-05	0.00134	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—HPRT1—gout	2.35e-05	0.00132	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PRPS2—gout	2.35e-05	0.00132	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PRPS1—gout	2.35e-05	0.00132	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ABCG2—gout	2.27e-05	0.00128	CbGpPWpGaD
Gefitinib—CYP2D6—Biological oxidations—POMC—gout	2.19e-05	0.00124	CbGpPWpGaD
Gefitinib—CYP2C9—Biological oxidations—POMC—gout	2.18e-05	0.00123	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CASP1—gout	2.08e-05	0.00117	CbGpPWpGaD
Gefitinib—EGFR—Immune System—IL1RN—gout	2.02e-05	0.00114	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—POMC—gout	2e-05	0.00113	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ABCG2—gout	1.99e-05	0.00112	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—BCKDHA—gout	1.9e-05	0.00107	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—POMC—gout	1.56e-05	0.000877	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PRPS2—gout	1.55e-05	0.000873	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—HPRT1—gout	1.55e-05	0.000873	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PRPS1—gout	1.55e-05	0.000873	CbGpPWpGaD
Gefitinib—CYP3A4—Biological oxidations—POMC—gout	1.43e-05	0.000809	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ABCG2—gout	1.23e-05	0.000695	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—POMC—gout	1.23e-05	0.000693	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—POMC—gout	1.18e-05	0.000668	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ABCG2—gout	1.16e-05	0.000657	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—gout	1.12e-05	0.000631	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—POMC—gout	1.12e-05	0.00063	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ABCG2—gout	1.06e-05	0.000598	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—POMC—gout	1.02e-05	0.000575	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—POMC—gout	9.86e-06	0.000556	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ABCG2—gout	9.53e-06	0.000537	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ABCG2—gout	9.3e-06	0.000524	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—gout	9.16e-06	0.000517	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ABCG2—gout	8.76e-06	0.000494	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ABCG2—gout	8.69e-06	0.00049	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—gout	8.35e-06	0.000471	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—POMC—gout	7.36e-06	0.000415	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—POMC—gout	6.6e-06	0.000372	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ABCG2—gout	5.73e-06	0.000323	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—POMC—gout	5.28e-06	0.000298	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—POMC—gout	4.99e-06	0.000281	CbGpPWpGaD
Gefitinib—ALB—Metabolism—POMC—gout	4.54e-06	0.000256	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—POMC—gout	4.08e-06	0.00023	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—POMC—gout	3.98e-06	0.000225	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—POMC—gout	3.75e-06	0.000212	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—POMC—gout	3.72e-06	0.00021	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—POMC—gout	2.45e-06	0.000138	CbGpPWpGaD
